Surface antigen-guided CRISPR screens identify regulators of myeloid leukemia differentiation.

Related articles

Image of a cancer cell dividing

eBlogs

04
17
25

Precision Medicine in Action: The Role of Personalized Cancer Vaccines

Precision oncology uses information on the patient's own tumor to create personalized therapies, such as RNA cancer vaccines. These therapies train a patient's own immune system to attack cancer.

read more
Representation of a deep neural network with inputs and outputs

eBlogs

03
14
25

Designing better RNA medicines with artificial intelligence

Designing RNA sequences that are stable and efficiently translated is complex. AI-driven tools are unlocking new possibilities, enabling optimized RNA design to accelerate therapeutic development.

read more

Sponsorships

02
24
25

Decoding Microproteins Across Evolution and Disease

Eclipsebio is proud to announce their sponsorship of the 2025 Gordon Research Conference on Decoding Microproteins Across Evolution and Disease in Barcelona.

read more
RNA molecules floating over a blue background

eBlogs

02
19
25

mRNA therapeutics – a new era in replacing traditional treatments

mRNA therapeutics are fundamentally transforming the way we approach modern medicine. In this eBlog we review how mRNA is providing rapid and scalable solutions.

read more